| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/18/2011 | CN101311165B Novel antihistaminic piperidine derivatives and intermediates for the preparation thereof |
| 05/18/2011 | CN101289450B Tyrosine phthalocyanines derivates, preparation thereof and applications in preparation of photodynamic drugs |
| 05/18/2011 | CN101190249B Composition for preventing and controlling high-altitude disease and preparation method thereof |
| 05/18/2011 | CN101189231B Novel cyclic aminophenylalkanoic acid derivative |
| 05/18/2011 | CN101143004B Moxa leaf rice paste and its making method |
| 05/18/2011 | CN101072875B Novel cancer antigen peptide and the use thereof |
| 05/17/2011 | US7943757 RNA interference mediated inhibition of intercellular adhesion molecule (ICAM) gene expression using short interfering nucleic acid (siNA) |
| 05/17/2011 | US7943665 Anticancer agents based on regulation of protein prenylation |
| 05/17/2011 | US7943645 Piperidine compounds for use as orexin receptor antagonist |
| 05/17/2011 | US7943643 Aryl substituted pyridines and the use thereof |
| 05/17/2011 | US7943639 Such as 6-benzenesulfonyl-4-piperazin-1-yl-quinoline hydrochloride; for treatment of central nervous system and/or 5- HT6 receptor related disorders; for weight gain/loss |
| 05/17/2011 | US7943635 Farnesyl-protein transferase inhibitors |
| 05/17/2011 | US7943627 2,4-diaminopyrimidine derivatives |
| 05/17/2011 | US7943616 Protein kinase inhibitors; astham; psoriasis; antiinflammatory agents; inflammatory bowel disorders |
| 05/17/2011 | US7943583 2-O-(β-D-glucopyranosyl) ascorbic acid, process for its production, and foods cosmetics containing compositions comprising it |
| 05/17/2011 | US7943574 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 05/17/2011 | US7943338 Autoimmune conditions and NADPH oxidase defects |
| 05/17/2011 | US7943316 Immunostimulatory oligonucleotides and uses thereof |
| 05/17/2011 | CA2493496C Antiaging composition |
| 05/17/2011 | CA2487840C Substituted 1-piperazinylacylpiperidine derivatives, their preparation and their therapeutic application |
| 05/17/2011 | CA2470365C 4-oxoquinoline compound and use thereof as hiv integrase inhibitor |
| 05/17/2011 | CA2463552C Treatment of neurodegenerative diseases and cancer of the brain |
| 05/17/2011 | CA2451521C Use of poly-glu, tyr for neuroprotective therapy |
| 05/17/2011 | CA2440726C Substituted benzofuran-2-carboxamides derivatives |
| 05/17/2011 | CA2437851C 2-alkylated-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block |
| 05/17/2011 | CA2425489C Therapeutic use of aerosolized s-nitrosoglutathione in cystic fibrosis |
| 05/17/2011 | CA2423358C Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 05/17/2011 | CA2413945C Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
| 05/17/2011 | CA2411642C Use of ingenanes for the activation of latent virus infection |
| 05/17/2011 | CA2401385C Protein matrix materials, devices and methods of making and using thereof |
| 05/17/2011 | CA2391923C Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 05/12/2011 | WO2011057243A2 Administration of plant expressed oral tolerance agents |
| 05/12/2011 | WO2011056599A2 Caged ceramide-1-phosphate derivatives |
| 05/12/2011 | WO2011055843A1 Retinoid compound |
| 05/12/2011 | WO2011055770A1 Fused heterocyclic compound |
| 05/12/2011 | WO2011055561A1 Protein crosslinking inhibitor and use thereof |
| 05/12/2011 | WO2011054845A1 Benzodiazepine bromodomain inhibitor |
| 05/12/2011 | WO2011054553A1 Benzodiazepine bromodomain inhibitor |
| 05/12/2011 | WO2011054301A1 Use of danshensu, notoginsenoside r1 or their combination in preparation of medicaments for preventing and treating diseases caused by microcirculation disorder |
| 05/12/2011 | WO2011010848A9 Multifunctional nanoparticles for fluorescence, mr and pet images comprising magnetic silica nanoparticles doped with a near-infrared (nir) dye allowing composite imaging of lymph nodes and deep organs, and a method for synthesising the same |
| 05/12/2011 | WO2011005473A9 Methods for treating or preventing fatigue |
| 05/12/2011 | US20110112283 Rna interference mediating small rna molecules |
| 05/12/2011 | US20110112280 Use of rgm and its modulators |
| 05/12/2011 | US20110112192 Verfahren zur geruchsextinktion |
| 05/12/2011 | US20110112114 Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease |
| 05/12/2011 | US20110112084 Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 05/12/2011 | US20110112076 Selective hydroxamic acid based mmp-12 and mmp-13 inhibitors |
| 05/12/2011 | US20110112062 Carbamate And Urea Inhibitors Of 11Beta-Hydroxysteroid Dehydrogenase 1 |
| 05/12/2011 | US20110111493 Compositions and Methods For Inhibiting Expression Of A Target Gene |
| 05/12/2011 | US20110111065 Low Temperature Ultrasonic Extraction Method for Plants |
| 05/12/2011 | US20110111060 Compositions, formulations, and methods for preventing and/or treating physical effects of alcohol consumption |
| 05/12/2011 | US20110111052 Method to generate a mixture of hydrogen peroxide gas and a carrier gas |
| 05/12/2011 | US20110111041 Bacterially derived intact minicells that encompass plasmid free functional nucleic acid for in vivo delivery to mammalian cells |
| 05/12/2011 | US20110111030 Method of Producing Progenitor Cells from Differentiated Cells |
| 05/12/2011 | US20110111009 Methods and formulations for enhancing the absorption and decreasing the absorption variability of orally administered drugs, vitamins and nutrients |
| 05/12/2011 | US20110111002 Transport and delivery of glutathione into human cells using gold nanoparticles |
| 05/12/2011 | US20110110986 High-yield activation of polymer surfaces for covalent attachment of molecules |
| 05/12/2011 | US20110110955 Antibody cancer immunotherapy |
| 05/12/2011 | US20110110945 Immunoglobulin Fusion Proteins and Methods of Making |
| 05/12/2011 | US20110110917 Human Aminoacyl-tRNA Synthetase Polypeptides Useful For The Regulation of Angiogenesis |
| 05/12/2011 | US20110110907 Composition of soluble indigestible fibers and of eukaryotic organisms with a polysaccharide wall, used in the well-being field |
| 05/12/2011 | US20110110905 Infant Colic Supplement |
| 05/12/2011 | US20110110903 Cell fusion promoter and utilization of the same |
| 05/12/2011 | US20110110888 Scaffold Coated and/or Impregnated with at Least One Bioactive Agent for Tissue Repair and Other Medical Applications |
| 05/12/2011 | US20110110862 Disease animal model for chronic pain |
| 05/12/2011 | US20110110850 Compounds for therapy and diagnosis |
| 05/12/2011 | CA2781322A1 Use of danshensu, notoginsenoside r1 or their combination in preparation of medicaments for preventing and treating diseases caused by microcirculation disorder |
| 05/12/2011 | CA2780362A1 Administration of plant expressed oral tolerance agents |
| 05/12/2011 | CA2779423A1 Benzodiazepine bromodomain inhibitor |
| 05/12/2011 | CA2779355A1 Benzodiazepine bromodomain inhibitor |
| 05/11/2011 | EP2319939A2 Gene expression profiling of inflammatory bowel disease |
| 05/11/2011 | EP2319870A2 Human antibodies that bind human IL-12 and methods for producing |
| 05/11/2011 | EP2319840A1 Aminopropylidene derivative |
| 05/11/2011 | EP2319838A1 Therapeutic Molecules and Methods-1 |
| 05/11/2011 | EP2319831A1 Novel pyrrole derivative having, as substituents, ureide group, aminocarbonyl group and bicyclic group which may have substituent |
| 05/11/2011 | EP2319826A1 Succinate salt of O-desmethyl-venlafaxin |
| 05/11/2011 | EP2319540A1 Sustained release pharmaceutical compounds to prevent abuse of controlled substances |
| 05/11/2011 | EP2319539A1 Prophylactic or therapeutic agent for axial myopia |
| 05/11/2011 | EP2319537A1 Stabilizer for lymph vessel |
| 05/11/2011 | EP2319535A2 Pharmaceutical composition for treatment of diseases caused by IL-6 production |
| 05/11/2011 | EP2319527A2 BAFF, inhibitors thereof and their use in the modulation of the B-cell response |
| 05/11/2011 | EP2319523A1 Serine protease inhibitors |
| 05/11/2011 | EP2319520A1 Immunostimulating agent |
| 05/11/2011 | EP2319519A1 Composition for inhibiting expression of target gene |
| 05/11/2011 | EP2319511A2 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 05/11/2011 | EP2319508A1 Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism |
| 05/11/2011 | EP2319493A2 Ophthalmic ointment composition comprising a drug, an ointment base and a solubilizing/dispersing agent |
| 05/11/2011 | EP2318052A1 Nanocrystal nano-emulsion |
| 05/11/2011 | EP2318051A2 In vitro diagnostic markers comprising carbon nanoparticles and kits |
| 05/11/2011 | EP2318003A1 Compositions for the treatment of fibrotic diseases or conditions |
| 05/11/2011 | EP1604665B1 C-kit kinase inhibitor |
| 05/11/2011 | EP1411929B1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 05/11/2011 | EP1163262B1 Phenylalanine derivatives |
| 05/11/2011 | EP1061803B1 Compositions of eprosartan |
| 05/11/2011 | EP1001755B1 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them |
| 05/11/2011 | CN1899614B Preparation for the prophylaxis of restenosis |
| 05/11/2011 | CN102056905A Novel uracil compound having inhibitory activity on human deoxyuridine triphosphatase or salt thereof |
| 05/11/2011 | CN102056894A Homocysteine synthase inhibitor |
| 05/11/2011 | CN102056630A Stabilizer for lymph vessel |
| 05/11/2011 | CN102056629A A photosensitising composition and its uses |